GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BMRA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Biomerica, Inc stock price ended at $0.760 on Thursday, after gaining 1.20%.
(Updated on Apr 18, 2024)

Sell candidate since Apr 03, 2024 Loss -8.92% PDF

The Biomerica, Inc stock price gained 1.20% on the last trading day (Thursday, 18th Apr 2024), rising from $0.751 to $0.760. During the last trading day the stock fluctuated 6.78% from a day low at $0.749 to a day high of $0.80. The price has risen in 6 of the last 10 days but is still down by -9.2% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 20 thousand more shares were traded than the day before. In total, 55 thousand shares were bought and sold for approximately $42.11 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.734 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -10.53% during the next 3 months and, with a 90% probability hold a price between $0.656 and $1.08 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BMRA Signals & Forecast

There are mixed signals in the stock today. The Biomerica, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.781 and $0.95. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 2.94%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Biomerica, Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Biomerica, Inc stock

Biomerica, Inc finds support from accumulated volume at $0.751 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0508 between high and low, or 6.78%. For the last week, the stock has had daily average volatility of 7.39%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BMRA) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Biomerica, Inc to open at $0.770, and during the day (based on 14 day Average True Range), to move between $0.691 and $0.83, which gives a possible trading interval of +/-$0.0687 (+/-9.05%) up or down from last closing price. If Biomerica, Inc takes out the full calculated possible swing range there will be an estimated 18.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.751 (1.18%) than the resistance at $0.81 (6.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Biomerica, Inc stock A Buy?

Biomerica, Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.780 Sell Candidate Unchanged

Predicted Opening Price for Biomerica, Inc of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$0.770 ( 1.28%) $0.760

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BMRA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.82 7.96 %
R2 0.80 5.41 %
R1 0.789 3.83 %
Current price: 0.760
Support S1 0.750 -1.27 %
S2 0.738 -2.85 %
S3 0.719 -5.40 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.89 16.79 %
R2 0.87 14.51 %
R1 0.81 6.79 %
Current price 0.760
Support S1 0.751 -1.18%
S2 0.738 -2.86%
S3 0 .

FAQ

What is the symbol for Biomerica, Inc Stock and on which exchange is it traded?
The symbol for Biomerica, Inc is BMRA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Biomerica, Inc Stock?
Biomerica, Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Biomerica, Inc Stock?
Biomerica, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biomerica, Inc Stock.

What's the current price of Biomerica, Inc Stock?
As of the end of day on the 2024-04-18, the price of an Biomerica, Inc (BMRA) share was $0.760.

What is the 52-week high and low for Biomerica, Inc Stock?
The 52-week high for Biomerica, Inc Stock is $2.13 and the 52-week low is $0.704.

What is the market capitalization of Biomerica, Inc Stock?
As of the 2024-04-18, the market capitalization of Biomerica, Inc is 12.784M.

When is the next earnings date for Biomerica, Inc?
The upcoming earnings date for Biomerica, Inc is Aug 23, 2024.
Click to get the best stock tips daily for free!

About Biomerica, Inc

Biomerica Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies... BMRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT